1 Elferink, J. G., "The role of calcium in neutrophil migration: the effect of calcium and calcium-antagonists in electroporated neutrophils" 31 : 864-869, 1992
2 Van Zwieten, P. A., "The pharmacological properties of lipophilic calcium antagonists" 2 : 5-9, 1998
3 Fuster, V., "The pathogenesis of coronary artery disease and the acute coronary syndromes (2)" 326 : 310-318, 1992
4 Sirmagul, B., "The effects of verapamil on stress- and histamine-induced gastric lesions in rats" 26 : 763-, 2004
5 Henry, P. D., "Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine" 68 : 1366-1369, 1989
6 Maslinska, D., "Some aspects of the inflammatory process" 36 : 199-204, 1998
7 Mohler, E. R. 3rd., "Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial Prospective Randomized Amlodipine Survival Evaluation" 30 : 35-41, 1997
8 Suleyman, H., "Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers" 58 : 692-699, 2006
9 Siflinger-Birnboim, A., "Regulation of endothelial permeability by second messengers" 4 : 87-98, 1996
10 Yamada, Y., "Protective effects of calcium channel blockers on hydrogen peroxide induced increases in endothelial permeability" 24 : 993-997, 1990
1 Elferink, J. G., "The role of calcium in neutrophil migration: the effect of calcium and calcium-antagonists in electroporated neutrophils" 31 : 864-869, 1992
2 Van Zwieten, P. A., "The pharmacological properties of lipophilic calcium antagonists" 2 : 5-9, 1998
3 Fuster, V., "The pathogenesis of coronary artery disease and the acute coronary syndromes (2)" 326 : 310-318, 1992
4 Sirmagul, B., "The effects of verapamil on stress- and histamine-induced gastric lesions in rats" 26 : 763-, 2004
5 Henry, P. D., "Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine" 68 : 1366-1369, 1989
6 Maslinska, D., "Some aspects of the inflammatory process" 36 : 199-204, 1998
7 Mohler, E. R. 3rd., "Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial Prospective Randomized Amlodipine Survival Evaluation" 30 : 35-41, 1997
8 Suleyman, H., "Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers" 58 : 692-699, 2006
9 Siflinger-Birnboim, A., "Regulation of endothelial permeability by second messengers" 4 : 87-98, 1996
10 Yamada, Y., "Protective effects of calcium channel blockers on hydrogen peroxide induced increases in endothelial permeability" 24 : 993-997, 1990
11 Bilici, D., "Protective effect of T-type calcium channel blocker in histamine-induced paw inflammation in rat" 44 : 527-531, 2001
12 Leslie, C. C., "Properties and regulation of cytosolic phospholipase A2" 272 : 16709-16712, 1997
13 Chen, L., "Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine" 30 : 569-575, 1997
14 Aditya, G. N., "Preliminary study on antiinflammatory effect of calcium channel blockers in albino rats" 29 : 132-134, 1997
15 Janssen, B. J., "Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats" 364 : 14-421, 2001
16 Houck, J. C., "Permeability factor contaminating hyaluronidase preparations" 3 : 447-451, 1979
17 Al-Naemi, H., "Nitric oxide protects venules against histamine-induced leaks" 7 : 215-223, 2000
18 Libby, P., "Molecular bases of the acute coronary syndromes" 91 : 2844-2850, 1995
19 Mason, R. P., "Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine" 31 : 275-281, 1999
20 Kramsch, D. M., "Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent" 62 : 119-124, 1997
21 Siflinger-Birnboim, A., "Involvement of Ca2+ in the H2O2-induced increase in endothelial permeability" 270 : 973-978, 1996
22 Elferink, J. G., "Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes" 32 : 1417-1420, 1982
23 Huang, Q., "Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability" 273 : 42-2451, 1997
24 Martinez, L. L., "Influence of verapamil and diclofenac on leukocyte migration in rats" 34 : 997-1001, 1999
25 Chand, N., "In vitro inhibition of allergic histamine release by calcium antagonists" 107 : 353-358, 1985
26 Liao, F., "Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice" 94 : 877-884, 1994
27 Salomone, S., "Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery" 354 : 505-512, 1996
28 De Souza, A. P., "Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection" 92 : 496-501, 2004
29 Gurdal, H., "Effects of calcium channel blockers on formalin-induced nociception and inflammation in rats" 44 : 290-296, 1992
30 Marzocco, S., "Effect of methylguanidine in carrageenaninduced acute inflammation in the rats" 26 : 341-350, 2004
31 Pitt, B., "Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators" 102 : 1503-1151, 2000
32 Oates, J. A., "Drugs affecting renal and cardiovascular function: Antihypertensive Agents and the Drug Therapy of Hypertension. In: Brunton L, editor. Godman and Gilman’s the pharmacological basis of therapeutics" Mc Graw-Hill 671-717, 2006
33 Mason, R. P., "Cytoprotective properties of a long-acting calcium channel blocker: new mechanism of action" 11 : 245A-, 1998
34 Cominacini, L., "Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells" 17 : 1837-1841, 1999
35 Tulenko, T. N., "Cholesterol, calcium and atherosclerosis: Is there a role forcalcium channel blockers in atheroprotection?" 62 : 55-66, 1997
36 Winter, C. A., "Carrageenininduced edema in hind paw of the rat as an assay for antiiflammatory drugs" 111 : 544-547, 1962
37 Carnevale, K. A., "Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1" 167 : 3414-3421, 2001
38 Abernethy, D. R., "Calcium-antagonist drugs" 341 : 1447-1457, 1999
39 Grossman, E., "Calcium antagonists" 47 : 34-57, 2004
40 El-Bizri, N., "Bradykinin induced a positive chronotropic effect via stimulation of T- and L-type calcium currents in heart cells" 81 : 247-258, 2003
41 Henry, P. D., "Atherosclerosis, calcium, and calcium antagonists" 72 : 456-459, 1985
42 Ross, R., "Atherosclerosis an inflammatory disease" 340 : 115-126, 1999
43 Kouoh, F., "Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils-a potential antiatherosclerotic property of calcium antagonists" 16 : 515-520, 2006
44 Suleyman, H., "Antiinflammatory effect of the aqueous extract from Rumex patientia L. roots" 65 : 141-148, 1999
45 Ramprasath, V. R., "Antiinflammatory effect of Semecarpus anacardium Linn. Nut extract in acute and chronic inflammatory conditions" 27 : 2028-2031, 2004
46 Suleyman, H., "Antiinflammatory activity of bis(3-aryl-3-oxo-propyl)methylamine hydrochloride in rat" 30 : 63-67, 2007
47 Suleyman, H., "Anti-inflammatory and antiulcerogenic effects of the aqueous extract of Lobaria pulmonaria (L.) Hoffm" 10 : 552-557, 2003
48 Suleyman, H., "Anti-inflammatory activity of 3-benzoyl-1-methyl-4-phenyl-4-piperidinol hydrochloride" 47 : 471-475, 1998
49 Procida, C., "Anti-hyaluronidase activity of some pyrazole derivatives" 47 : 159-163, 1971
50 Neto, A. G., "Analgesic and anti-inflammatory activity of a crude root extract of Pfaffia glomerata (Spreng) Pedersen" 96 : 87-91, 2005
51 Tulenko, T. N., "Actions of the charged dihydropyridine amlodipine in a cell culture model of dietary atherosclerosis" 126 : 11-17, 1995